Tel Aviv, Israel / Vancouver, Canada, Sept. 18, 2023 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (NASDAQ: CMND) (CSE: CMND), (FSE: CWY) (“Clearmind”), a biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve major under-treated health problems, today announced the closing of its United States only public offering made on a reasonable best efforts…


Previous articlePT442 – Burning Questions About Burning Man: Mud, Ebola, and the Big Krab Car
Next articleCOMPASS Pathways appoints Daphne Karydas to its Board of Directors